BN
Brookfield Corporation
BN has the edge over JPM overall, supported by stronger valuation and stronger modeled upside.
JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
BN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
BN's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like BN.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
BN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $41.64 | — |
| Cheap | 20x | $10.94 | -74% |
| Fair | 71x | $39.79 | -4.4% |
| Current | 75x | $41.64 | — |
| Expensive | 130x | $72.77 | +75% |
Historical ranges are pointers, not guarantees.
BN's PE is in its fair range at 75x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over BN in the historical PE scenario, which offers more potential upside but is not a forecast.
BN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
BN has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
BN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.22 | +475% |
| Q2 2026 | $0.56 | +87% |
| Q1 2026 | $0.52 | +160% |
| Q4 2025 | $0.49 | +133% |
| Q3 2025 | $0.36 | +13% |
| Q2 2025 | $0.30 | -21% |
| Q1 2025 | $0.20 | -50% |
| Q4 2024 | $0.21 | -49% |
| Q3 2024 | $0.32 | +$0.34 |
BN's earnings per share have fallen from their peak: $0.56 over the past year, against $1.66 in late 2019.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over BN on earnings, with more consistent year-over-year improvement.
BN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $19.3B | +6.6% |
| Q1 2026 | $18.4B | +2.5% |
| Q4 2025 | $21.2B | +9% |
| Q3 2025 | $18.9B | -8.3% |
| Q2 2025 | $18.1B | -22% |
| Q1 2025 | $17.9B | -22% |
| Q4 2024 | $19.4B | -21% |
| Q3 2024 | $20.6B | -16% |
BN's revenue is recovering but still below its 2023 peak: $19.3B last quarter, up 6.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 24% | +1.3 points |
| Q1 2026 | 24% | -1.1 points |
| Q4 2025 | 42% | +16 points |
| Q3 2025 | 23% | -2.9 points |
| Q2 2025 | 23% | +6.1 points |
| Q1 2025 | 25% | +8.2 points |
| Q4 2024 | 26% | +9.9 points |
| Q3 2024 | 26% | +12 points |
BN's operating margin was 24% last quarter, up 1.3 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over BN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over BN on profitability, with a higher operating margin.
BN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.8B | -$1B |
| Q1 2026 | -$5.6B | -$4.5B |
| Q4 2025 | $0 | +$24.5M |
| Q3 2025 | -$919.1M | -238% |
| Q2 2025 | -$750M | +$943.6M |
| Q1 2025 | -$1.1B | +$1.5B |
| Q4 2024 | -$24.5M | +$1.2B |
| Q3 2024 | $665.5M | -48% |
BN's free cash flow was −$8.3B over the past year, against −$1.2B the year before. Free cash flow isn't a meaningful measure for financial services companies like BN.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
BN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +0.3% | +8M shares |
| 3 years | 0% | -600K shares |
| 5 years | +1.8% | +42M shares |
| Available history | +7.3% | +162M shares |
BN has 2.4B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $109.6M |
| Q1 2026 | $431.9M |
| Q4 2025 | — |
| Q3 2025 | $35.4M |
| Q2 2025 | $293.6M |
| Q1 2025 | $567.3M |
| Q4 2024 | $136.3M |
| Q3 2024 | $79.4M |
BN spent $577M buying back its own shares over the past year, down 46% from the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over BN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
BN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 7.5x | High |
| Q1 2026 | 7.5x | High |
| Q4 2025 | 9.0x | High |
| Q3 2025 | 7.9x | High |
| Q2 2025 | 7.7x | High |
| Q1 2025 | 8.1x | High |
| Q4 2024 | 7.5x | High |
| Q3 2024 | 7.3x | High |
BN's net debt is about 7.5 years of its operating earnings (EBITDA), down from 7.7 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BN.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over BN on leverage, with a lower net debt burden relative to earnings.
BN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.0 | Neutral |
| Stochastic | 51.5 | Neutral |
BN's weekly RSI is 53 (neutral) and its Stochastic is 52 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
BN PE vs Financial Services Sector
| Metric | BN | Sector median | Relative |
|---|---|---|---|
| PE | 75x | 13x | 473% above |
| PE % | 54 | 63 | 9 pts below |
BN is trading at 75x earnings, a 473% premium to the Financial Services sector's median of 13x.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over BN on valuation relative to its sector.
BN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.5 | 8.2% above |
| 20 week MA | $40.5 | 2.8% above |
| 50 week MA | $43.0 | 3.1% below |
| 100 week MA | $41.8 | 0.4% below |
| 200 week MA | $34.2 | 22% above |
BN's trend is mixed: it's above three of its five weekly moving averages, and 22% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over BN on trend strength, trading above more of its moving averages.
BN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.7 | $21.9 | +5.6% |
| 2021 | $21.9 | $32.3 | +48% |
| 2022 | $32.3 | $21.2 | -35% |
| 2023 | $21.2 | $26.8 | +26% |
| 2024 | $26.8 | $38.1 | +43% |
| 2025 | $38.1 | $46.7 | +23% |
| 2026 YTD | $46.7 | $41.6 | -11% |
BN has finished higher in five of the last six years. It's down 11% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over BN on returns for 2026, with the stronger performance.